Distributed Manufacturing in Medicine

<strong>Distributed Manufacturing in Medicine</strong>Nick Lambert | CEO, Dock LabsJim Nasr | CEO, Acoer <strong>Moderator</strong>The conversation pivots around what is actually working now in the blockchain in healthcare field including:<ul><li>Current trends in DIDs…what’s working, what’s not<ul><li>Usability and wallets</li><li>Blockchain for medicine – is it helping decrease counterfeit medicine production?</li><li>Decentralization, collaboration, and efficiency</li><li>Advantages &amp; disadvantages on decentralizing Pharma manufacturing</li><li>Implications of collaborations, cross-border transactions for blockchain-enabled transactions and impact of immutability</li><li>Interoperability, scalability, and economic viability for life sciences</li><li>Regulation and the implications in life sciences</li><li>Tokenization &amp; Web 3 trends</li><li>How to increase adoption and what the incentives are for Pharma</li><li>Prediction(s)</li></ul></li></ul>